Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred


SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4315
See all formats and pricing

 


 
 

Select Volume and Issue

Issues

30,00 € / $42.00 / £23.00

Get Access to Full Text

Apolipoprotein(a): Structure-Function Relationship at the Lysine-Binding Site and Plasminogen Activator Cleavage Site

Eduardo Anglés-Cano / Gertrudis Rojas

Citation Information: Biological Chemistry. Volume 383, Issue 1, Pages 93–99, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2002.009, June 2005

Publication History

Published Online:
2005-06-01

Abstract

Apolipoprotein(a) [apo(a)] is the distinctive glycoprotein of lipoprotein Lp(a), which is disulfide linked to the apo B100 of a low density lipoprotein particle. Apo(a) possesses a high degree of sequence homology with plasminogen, the precursor of plasmin, a fibrinolytic and pericellular proteolytic enzyme. Apo(a) exists in several isoforms defined by a variable number of copies of plasminogenlike kringle 4 and single copies of kringle 5, and the protease region including the backbone positions for the catalytic triad (Ser, His, Asp). A lysinebinding site that is similar to that of plasminogen kringle 4 is present in apo(a) kringle IV type 10. These kringle motifs share some amino acid residues (Asp55, Asp57, Phe64, Tyr62, Trp72, Arg71) that are key components of their lysinebinding site. The spatial conformation and the function of this site in plasminogen kringle 4 and in apo(a) kringle IV-10 seem to be identical as indicated by (i) the ability of apo(a) to compete with plasminogen for binding to fibrin, and (ii) the neutralisation of the lysinebinding function of these kringles by a monoclonal antibody that recognises key components of the lysinebinding site. In contrast, the lysinebinding site of plasminogen kringle 1 contains a Tyr residue at positions 64 and 72 and is not recognised by this antibody. Plasminogen bound to fibrin is specifically recognised and cleaved by the tissuetype plasminogen activator at Arg561-Val562, and is thereby transformed into plasmin. A SerIle substitution at the activation cleavage site is present in apo(a). Reinstallation of the ArgVal peptide bond does not ensure cleavage of apo(a) by plasminogen activators. These data suggest that the stringent specificity of tissuetype plasminogen activator for plasminogen requires molecular interactions with structures located remotely from the activation disulfide loop. These structures ensure second site interactions that are most probably absent in apo(a).

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Rainer Vormittag, Thomas Vukovich, Milena Stain, Stephan Lehr, Erich Minar, and Ingrid Pabinger
Thrombosis Research, 2007, Volume 120, Number 1, Page 15
[2]
Won Chan Choi, Min Young Kim, Chang Woo Suh, and Eun Kyu Lee
Process Biochemistry, 2005, Volume 40, Number 5, Page 1967
[3]
Hong‐Xia Zhang, Lei Fang, Jian Cheng, Zheng Wei, and Zi‐Chun Hua
Preparative Biochemistry and Biotechnology, 2005, Volume 35, Number 1, Page 17
[4]
Christos S Katsouras, Loukas D Tsironis, Moses Elisaf, John A Goodevenos, Lampros K Michalis, and Alexandros D Tselepis
Future Cardiology, 2005, Volume 1, Number 4, Page 509
[5]
Martin Hermel, Wendelin Dailey, Michael Trese, and Michael K. Hartzer
Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, Volume 249, Number 1, Page 37
[6]
Enzo Emanuele, Emmanouil Peros, Carmine Tomaino, Enrica Feudatari, Livia Bernardi, Giuliano Binetti, Raffaele Maletta, Giuseppe Micieli, Amalia C. Bruni, and Diego Geroldi
Dementia and Geriatric Cognitive Disorders, 2004, Volume 18, Number 2, Page 189

Comments (0)

Please log in or register to comment.